Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CAR-pNK cell immunotherapy for MUC1-positive relapsed or refractory solid tumors; current status is not provide…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating Anti-Mucin1 (MUC1) CAR T cells in patients with MUC1-positive advanced refractory solid tumors across several can…
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the combination of chemotherapy and radiation therapy for non-small cell lun…
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations [Phase 2]
A Phase 2 trial is evaluating stereotactic body radiotherapy in multi-metastatic non-small cell lung cancer patients who are pan-negative fo…
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase II study compares stereotactic body radiotherapy (SBRT) with conventional radiotherapy in patients with oligometastatic non-small ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-11-25Clinical Trial Update: Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients
This clinical trial update examines PD-1 and PD-L1 expression on blood cells and tumor tissue to evaluate their potential as prognostic targ…
-
CLINICAL_TRIALS research · 2016-11-23Clinical Trial Update: Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M [Phase 3]
Open-label Phase 3 study evaluating the efficacy and safety of osimertinib (AZD9291) in brain metastases from EGFR T790M-positive non-small …
-
CLINICAL_TRIALS research · 2016-11-21Clinical Trial Update: uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung [Phase 2]
Clinical trial update describing Phase 2 evaluation of uPAR-PET imaging as a prognostic tool in patients with Non-small cell lung cancer, ma…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy
This observational study update reports outcomes for patients with non-small cell lung cancer who achieved long progression-free survival af…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer
This document reports an observational study evaluating Tarceva (erlotinib) as first-line maintenance therapy in routine practice for patien…
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in Patients With Non-Small Cell Lung Cancer
An observational study evaluating Tarceva (erlotinib) in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2016-11-02Clinical Trial Update: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
An observational study update assessing first-line erlotinib (Tarceva) in advanced EGFR mutation-positive non-small cell lung cancer (GERTAC…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Clinical trial update examining dynamic changes of circulating tumor DNA in patients with late-stage non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC
This clinical trial update covers ALK, ROS1, and MET mutations detected in plasma ctDNA from non-small cell lung cancer patients, including …
-
CLINICAL_TRIALS research · 2016-10-24Clinical Trial Update: Micro RNA Genetic Signature in NSCLC Egyptian Patients
A clinical trial evaluating microRNA genetic signatures in Egyptian patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients [Phase 3]
This update describes a Phase 3 clinical trial evaluating systemic chemotherapy combined with recombinant human adenovirus type 5 and endost…
-
CLINICAL_TRIALS research · 2016-10-13Clinical Trial Update: Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance [Phase 2]
Phase 2 study assessing gefitinib in combination with chemotherapy or antiangiogenic therapy in non-small-cell lung cancer patients with BIM…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC [Phase 2]
This document provides a Phase 2 trial update on neoadjuvant concurrent chemoradiation with weekly docetaxel and cisplatin for resectable II…
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy [NA]
Clinical trial update examining how different anesthetics affect alarmins in patients with Non-Small Cell Lung Cancer undergoing pulmonary l…
-
CLINICAL_TRIALS research · 2016-09-21Clinical Trial Update: Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET) [Phase 2]
Phase 2 COMET trial evaluating Tumor Treating Fields at 150 kHz in non-small cell lung cancer patients with 1-5 brain metastases after stand…
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
This clinical trial update describes a prospective study evaluating urinary circulating tumor DNA detection in non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2016-09-20Clinical Trial Update: Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy [Phase 3]
Phase 3 clinical trial update comparing sublobar resection versus lobectomy for elderly patients with early-stage non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2016-09-19Clinical Trial Update: First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating thymosin alpha-1 in combination with standard therapy as first-line treatment for patients with EGFR-m…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating combinations of D-CIK immunotherapy with anti-PD-1 therapy in refractory solid tumors, including hepatoce…
-
CLINICAL_TRIALS research · 2016-09-01Clinical Trial Update: EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the combination of EGFR-TKIs with chemotherapy as first-line therapy for adv…